K36 Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2021-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.k36tx.com
A Study of an MMSET Inhibitor in Patients with Relapsed and Refractory Multiple Myeloma
Phase 1
Recruiting
- Conditions
- MyelomaMultiple MyelomaMyeloma Multiple
- Interventions
- First Posted Date
- 2022-12-15
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- K36 Therapeutics, Inc.
- Target Recruit Count
- 125
- Registration Number
- NCT05651932
- Locations
- 🇺🇸
Atrium Health, Levine Cancer Institute, Charlotte, North Carolina, United States
🇺🇸University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇫🇷Universitaire de Lille, Villeneuve-d'Ascq, France